
\begin{tabular}{l|l|l|l|l|l|l|l|l}
\hline
Dependent: Trt &   & No study drug & Ivermectin & Regeneron & Remdesivir & Favipiravir & Molnupiravir & Nirmatrelvir\\
\hline
Site & br003 & 26 (9.9) & 0 (0.0) & 0 (0.0) & 9 (13.4) & 16 (14.0) & 0 (0.0) & 4 (2.5)\\
\hline
 & la008 & 3 (1.1) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 1 (1.5) & 4 (2.5)\\
\hline
 & pk001 & 4 (1.5) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0)\\
\hline
 & th001 & 224 (85.5) & 40 (90.9) & 84 (95.5) & 54 (80.6) & 96 (84.2) & 65 (98.5) & 150 (94.9)\\
\hline
 & th057 & 3 (1.1) & 2 (4.5) & 1 (1.1) & 2 (3.0) & 2 (1.8) & 0 (0.0) & 0 (0.0)\\
\hline
 & th058 & 2 (0.8) & 2 (4.5) & 3 (3.4) & 2 (3.0) & 0 (0.0) & 0 (0.0) & 0 (0.0)\\
\hline
Age & Mean (SD) & 31.1 (8.1) & 30.0 (7.0) & 27.9 (7.3) & 30.1 (8.2) & 30.2 (7.5) & 31.3 (7.5) & 31.3 (8.9)\\
\hline
BMI & Mean (SD) & 23.2 (4.1) & 22.3 (3.2) & 22.1 (3.1) & 22.7 (3.1) & 23.1 (3.7) & 23.1 (4.0) & 23.0 (3.8)\\
\hline
Weight & Mean (SD) & 63.0 (13.6) & 61.6 (12.3) & 60.4 (12.3) & 63.9 (11.0) & 63.0 (13.6) & 63.4 (14.7) & 61.5 (12.3)\\
\hline
Baseline.viral.load & Mean (SD) & 5.5 (1.3) & 5.6 (1.2) & 5.6 (1.0) & 5.5 (1.1) & 5.5 (1.0) & 5.6 (1.1) & 5.5 (1.3)\\
\hline
Sex & Female & 173 (66.0) & 24 (54.5) & 55 (62.5) & 35 (52.2) & 71 (62.3) & 37 (56.1) & 109 (69.0)\\
\hline
 & Male & 89 (34.0) & 20 (45.5) & 33 (37.5) & 32 (47.8) & 43 (37.7) & 29 (43.9) & 49 (31.0)\\
\hline
Fever\_Baseline & 0 & 191 (72.9) & 31 (70.5) & 66 (75.0) & 48 (71.6) & 88 (77.2) & 54 (81.8) & 101 (63.9)\\
\hline
 & 1 & 53 (20.2) & 13 (29.5) & 22 (25.0) & 19 (28.4) & 26 (22.8) & 12 (18.2) & 43 (27.2)\\
\hline
 & (Missing) & 18 (6.9) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 14 (8.9)\\
\hline
Variant & - & 5 (1.9) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 1 (0.6)\\
\hline
 & AY.30 & 2 (0.8) & 2 (4.5) & 1 (1.1) & 1 (1.5) & 2 (1.8) & 0 (0.0) & 0 (0.0)\\
\hline
 & AY.85 & 2 (0.8) & 6 (13.6) & 7 (8.0) & 2 (3.0) & 5 (4.4) & 0 (0.0) & 0 (0.0)\\
\hline
 & B.1.617.2 & 6 (2.3) & 4 (9.1) & 5 (5.7) & 7 (10.4) & 4 (3.5) & 0 (0.0) & 0 (0.0)\\
\hline
 & BA.1 & 5 (1.9) & 3 (6.8) & 3 (3.4) & 6 (9.0) & 7 (6.1) & 0 (0.0) & 0 (0.0)\\
\hline
 & BA.1.1 & 8 (3.1) & 11 (25.0) & 12 (13.6) & 14 (20.9) & 14 (12.3) & 0 (0.0) & 0 (0.0)\\
\hline
 & BA.2 & 52 (19.8) & 18 (40.9) & 30 (34.1) & 37 (55.2) & 42 (36.8) & 5 (7.6) & 1 (0.6)\\
\hline
 & BA.2.75 & 42 (16.0) & 0 (0.0) & 5 (5.7) & 0 (0.0) & 5 (4.4) & 28 (42.4) & 30 (19.0)\\
\hline
 & BA.4 & 2 (0.8) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 3 (2.6) & 2 (3.0) & 3 (1.9)\\
\hline
 & BA.5 & 41 (15.6) & 0 (0.0) & 25 (28.4) & 0 (0.0) & 32 (28.1) & 28 (42.4) & 25 (15.8)\\
\hline
 & BQ.1 & 1 (0.4) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 1 (0.6)\\
\hline
 & EG.2 & 1 (0.4) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0)\\
\hline
 & EG.5.1.1 & 2 (0.8) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 1 (0.6)\\
\hline
 & FL.10 & 1 (0.4) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 2 (1.3)\\
\hline
 & FL.2 & 3 (1.1) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0)\\
\hline
 & FL.2.2.1 & 1 (0.4) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0)\\
\hline
 & FL.4 & 4 (1.5) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 9 (5.7)\\
\hline
 & GE.1 & 2 (0.8) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 1 (0.6)\\
\hline
 & GR.1 & 1 (0.4) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 1 (0.6)\\
\hline
 & GY.7 & 1 (0.4) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0)\\
\hline
 & HF.1 & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 1 (0.6)\\
\hline
 & XBB & 29 (11.1) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 3 (4.5) & 23 (14.6)\\
\hline
 & XBB.1.16.11 & 1 (0.4) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 1 (0.6)\\
\hline
 & XBB.1.16.14 & 1 (0.4) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0)\\
\hline
 & XBB.1.16.2 & 2 (0.8) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0)\\
\hline
 & XBB.1.16.22 & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 1 (0.6)\\
\hline
 & XBB.1.16.3 & 1 (0.4) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0)\\
\hline
 & XBB.1.16.5 & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 1 (0.6)\\
\hline
 & XBB.1.5-like & 44 (16.8) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 51 (32.3)\\
\hline
 & XBB.1.5.13 & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 1 (0.6)\\
\hline
 & XBB.1.5.36 & 1 (0.4) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0)\\
\hline
 & XBB.1.5.39 & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 1 (0.6)\\
\hline
 & XBB.1.5.57 & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 1 (0.6)\\
\hline
 & XBB.2.3.11 & 1 (0.4) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0)\\
\hline
 & XBB.2.3.3 & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 0 (0.0) & 2 (1.3)\\
\hline
Symptom\_onset & Mean (SD) & 2.1 (0.8) & 2.3 (0.8) & 2.2 (0.8) & 2.4 (0.8) & 2.1 (0.7) & 2.1 (0.7) & 1.9 (0.7)\\
\hline
Vaccinated & No & 10 (3.8) & 1 (2.3) & 3 (3.4) & 3 (4.5) & 2 (1.8) & 1 (1.5) & 5 (3.2)\\
\hline
 & Yes & 252 (96.2) & 43 (97.7) & 85 (96.6) & 64 (95.5) & 112 (98.2) & 65 (98.5) & 153 (96.8)\\
\hline
\end{tabular}
